1. Home
  2. ZURA

as 11-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Founded: 2022 Country:
United States
United States
Employees: N/A City: LA JOLLA
Market Cap: 292.1M IPO Year: N/A
Target Price: $15.80 AVG Volume (30 days): 338.7K
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.66 EPS Growth: N/A
52 Week Low/High: $2.00 - $6.35 Next Earning Date: 11-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

ZURA Daily Stock ML Predictions

Share on Social Networks: